Item 16. Form 10-K Summary

None.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.



		CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
		By:	/s/ DAVID R. SMITH
		David R. Smith
Date:	February 14, 2017	Corporate Executive Vice President, Chief Financial Officer and Chief Accounting Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the registrant and in the capacities indicated below and on the dates indicated.



Signatures		Title	Date
By:	/s/ JAMES C. FOSTER	President, Chief Executive Officer and Chairman	February 14, 2017
	James C. Foster

By:	/s/ DAVID R. SMITH	Corporate Executive Vice President, Chief	February 14, 2017
	David R. Smith	Financial Officer and Chief Accounting Officer

By:	/s/ ROBERT J. BERTOLINI	Director	February 14, 2017
	Robert J. Bertolini

By:	/s/ STEPHEN D. CHUBB	Director	February 14, 2017
	Stephen D. Chubb

By:	/s/ GEORGE E. MASSARO	Director	February 14, 2017
	George E. Massaro

By:	/s/ DEBORAH KOCHEVAR	Director	February 14, 2017
	Deborah Kochevar

By:	/s/ GEORGE M. MILNE, JR.	Director	February 14, 2017
	George M. Milne, Jr.

By:	/s/ C. RICHARD REESE	Director	February 14, 2017
	C. Richard Reese

By:	/s/ CRAIG B. THOMPSON	Director	February 14, 2017
	Craig B. Thompson

By:	/s/ RICHARD F. WALLMAN	Director	February 14, 2017
	Richard F. Wallman

EXHIBIT INDEX



Exhibit No.	Description	Filed with this Form 10-K	Incorporation by Reference
Form	Filing Date	Exhibit No.
3.1	Second Amended and Restated Certificate of Incorporation of Charles River Laboratories International, Inc. dated June 5, 2000		S-1/A	June 23, 2000	3.1
3.2	Fifth Amended and Restated By-Laws of Charles River Laboratories International, Inc.		8-K	May 16, 2016	3.2
4.1	Form of Common Stock certificate, $0.01 par value, of Charles River Laboratories International, Inc.		S-1	June 23, 2000	4.1
4.2	Charles River Laboratories International, Inc. Form of Performance Share Unit granted under the 2007 Incentive Plan		10-K	February 27, 2013	4.4
4.3	Charles River Laboratories International, Inc. Form of Performance Share Unit granted under the 2016 Incentive Plan	X
10.1*	Charles River Laboratories International, Inc. 2007 Incentive Plan, as amended		10-K	February 17, 2015	10.13
10.2*	Charles River Laboratories International, Inc. 2016 Incentive Plan		10-Q	August 3, 2016	10.1
10.3*	Charles River Laboratories International, Inc. Form of Stock Option granted under the 2007 Incentive Plan, as amended		10-K	February 20, 2008	10.17
10.4*	Charles River Laboratories International, Inc. Form of Stock Option granted under the 2016 Incentive Plan	X
10.5*	Charles River Laboratories International, Inc. Form of Restricted Stock Award granted under the 2007 Incentive Plan, as amended		10-K	February 20, 2008	10.18
10.6*	Charles River Laboratories International, Inc. Form of Restricted Stock Unit granted under the 2007 Incentive Plan	X
10.7*	Charles River Laboratories International, Inc. Form of Restricted Stock Unit granted under the 2016 Incentive Plan	X
10.8*	Charles River Corporate Officer Separation Plan dated April 30, 2010		10-Q	August 3, 2010	10.1
10.9*	Form of Change in Control Agreement		10-K	February 23, 2009	10.7
10.10*	Executive Incentive Compensation Plan dated January 1, 2016		10-K	February 12, 2016	10.4
10.11*	Charles River Laboratories International, Inc. Non-Employee Directors Deferral Plan dated April 5, 2016		10-Q	May 4, 2016	10.1
10.12*	Charles River Laboratories, Inc. Executive Life Insurance/Supplemental Retirement Income Plan		10-K	March 9, 2005	10.23
10.13*	Charles River Laboratories amended and restated Deferred Compensation Plan, as amended		10-K	February 27, 2012	10.11
10.14*	Amended and Restated Deferred Compensation Plan Document dated July 17, 2012		10-Q	August 7, 2012	10.1
10.15*	Letter Agreements with Davide Molho dated May 22, 2009		10-K	February 23, 2011	10.17
10.16*	Agreement between Thomas Ackerman and Charles River Laboratories, Inc. dated February 25, 2015		8-K	February 27, 2015	99.10
10.17*	Agreement between David Smith and Charles River Laboratories, Inc. dated March 3, 2015		10-K	February 12, 2016	10.16
10.18	Charles River Laboratories International, Inc. Seventh Amended and Restated Credit Agreement dated March 30, 2016		8-K	April 5, 2016	10.1
21.1	Subsidiaries of Charles River Laboratories International, Inc.	X
23.1	Consent of PricewaterhouseCoopers LLP	X
31.1	Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer	X
31.2	Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer	X
32.1	Section 1350 Certification of the Chief Executive Officer and Chief Financial Officer	X
101.INS	eXtensible Business Reporting Language (XBRL) Instance Document	X
101.SCH	XBRL Taxonomy Extension Schema	X
101.CAL	XBRL Taxonomy Extension Calculation Linkbase	X



Exhibit No.	Description	Filed with this Form 10-K	Incorporation by Reference
Form	Filing Date	Exhibit No.
101.DEF	XBRL Taxonomy Extension Definition Linkbase	X
101.LAB	XBRL Taxonomy Extension Labels Linkbase	X
101.PRE	XBRL Taxonomy Extension Presentation Linkbase	X
* Management contract or compensatory plan, contract or arrangement.

Previous: Item 15. (a)(1) and (2) Financial Statements and Schedules